| 7 | urotensin IIIBA
01/2013
-
05/2003 |
| 6 | GSK2798745IBA
04/2024
-
08/2019 |
| 4 | p38 Mitogen-Activated Protein KinasesIBA
09/2009
-
12/2003 |
| 3 | UrotensinsIBA
01/2013
-
08/2008 |
| 3 | SaltsIBA
01/2012
-
12/2003 |
| 2 | Oxygen (Dioxygen)IBA
04/2024
-
08/2010 |
| 2 | Ion Channels (Ion Channel)IBA
09/2021
-
08/2019 |
| 2 | Proteins (Proteins, Gene)FDA Link
10/2020
-
06/2009 |
| 2 | SulfonamidesIBA
12/2018
-
11/2018 |
| 2 | CytokinesIBA
08/2012
-
12/2003 |
| 2 | rho-Associated KinasesIBA
11/2008
-
01/2007 |
| 2 | NG-Nitroarginine Methyl Ester (L-NAME)IBA
08/2008
-
04/2005 |
| 2 | SB-239063ANIBA
04/2005
-
12/2003 |
| 2 | Vasoconstrictor AgentsIBA
03/2004
-
05/2003 |
| 1 | ChlorineIBA
04/2024 |
| 1 | Purinergic P2X ReceptorsIBA
07/2021 |
| 1 | Adenosine Triphosphate (ATP)IBA
07/2021 |
| 1 | Biomarkers (Surrogate Marker)IBA
01/2021 |
| 1 | LipopolysaccharidesIBA
10/2020 |
| 1 | CationsIBA
10/2020 |
| 1 | SulfonesIBA
12/2018 |
| 1 | pyrrolidineIBA
12/2018 |
| 1 | C.I. direct red 80IBA
07/2013 |
| 1 | salicylhydroxamic acid (SHAM)IBA
07/2013 |
| 1 | Atrial Natriuretic Factor (ANF)IBA
07/2013 |
| 1 | Epoxide HydrolasesIBA
07/2013 |
| 1 | CollagenIBA
07/2013 |
| 1 | SmokeIBA
07/2013 |
| 1 | Connective Tissue Growth FactorIBA
04/2013 |
| 1 | N- ((4- bromo- 2- ((trifluoromethyl)oxy)phenyl)methyl)- 1- (4- methyl- 6- (methylamino)- 1,3,5- triazin- 2- yl)- 4- piperidinecarboxamideIBA
04/2013 |
| 1 | N- ((4- cyano- 2- (trifluoromethyl)phenyl)methyl)- 3- ((4- methyl- 6- (methylamino)- 1,3,5- triazin- 2- yl)amino)cyclohexanecarboxamideIBA
04/2013 |
| 1 | 4'-(1-(((6,7-dichloro-3- oxo- 2,3- dihydro- 4H- 1,4- benzoxazin- 4- yl)acetyl)(methyl)amino)- 2- (4- morpholinyl)ethyl)- 4- biphenylcarboxylic acidIBA
01/2013 |
| 1 | Methacholine Chloride (Methacholine)FDA Link
01/2013 |
| 1 | Bronchodilator Agents (Bronchodilators)IBA
01/2013 |
| 1 | LipidsIBA
08/2012 |
| 1 | Glucose (Dextrose)FDA LinkGeneric
08/2012 |
| 1 | ApolipoproteinsIBA
08/2012 |
| 1 | AdipokinesIBA
08/2012 |
| 1 | BAY 60-4552IBA
01/2012 |
| 1 | Soluble Guanylyl CyclaseIBA
01/2012 |
| 1 | LDL CholesterolIBA
05/2011 |
| 1 | N- ((1- (cyclopropylethyl)- 6- fluoro- 4- hydroxy- 2- oxo- 1,2- dihydro- 3- quinolinyl)carbonyl)glycineIBA
08/2010 |
| 1 | Transcription Factors (Transcription Factor)IBA
08/2010 |
| 1 | Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
08/2010 |
| 1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2009 |
| 1 | Interleukin-1beta (Interleukin 1 beta)IBA
09/2009 |
| 1 | rofecoxib (Vioxx)FDA Link
09/2009 |
| 1 | ReninIBA
09/2009 |
| 1 | Anti-Inflammatory Agents (Anti-Inflammatories)IBA
09/2009 |
| 1 | AldosteroneIBA
09/2009 |
| 1 | 6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA
09/2009 |
| 1 | Niacinamide (Nicotinamide)FDA LinkGeneric
09/2009 |
| 1 | Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2009 |
| 1 | Apolipoproteins E (ApoE)IBA
06/2009 |
| 1 | BuffersIBA
08/2008 |
| 1 | arginine methyl esterIBA
08/2008 |
| 1 | Ruthenium RedIBA
08/2008 |
| 1 | N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA
08/2008 |
| 1 | Nitric Oxide Synthase (NO Synthase)IBA
08/2008 |